SNT
Click for more information
8.33% 3.9¢ syntara limited

fda approves aridol phase 3 trial!, page-2

  1. fetuandrangi
    291 Posts.
    clock Created with Sketch.
    23/12/04
    10:03
    Post #: 730409
    nice annoucement , I rekon it will bounce between 75/85 until we get a liciencing agreement with a european distributor next year some time.

    the key here is that they rekon it will take 6month for trails and fda approval
    PXS Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
RDN Preliminary interpretation of Andover South reveals key NE-trending corridor hosting lithium mineralization
right-arrow Created with Sketch.
NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.9¢ 		Change
0.003(8.33%) 		Mkt cap ! $53.54M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $80.41K 2.085M

Buyers (Bids)

No. Vol. Price($)
2 152202 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 25989 3
View Market Depth
Last trade - 16.10pm 27/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.